Novel compounds targeting the enterohemorrhagic Escherichia coli type three secretion system reveal insights into mechanisms of secretion inhibition
Riccardo Zambelloni; James P.R. Connolly; Alejandro Huerta Uribe; Karl Burgess; Rodolfo Marquez; Andrew J. Roe
Author Information: Institute of Infection, Immunity & Inflammation, College of Medical, Veterinary and Life Sciences
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.